Literature DB >> 8006580

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.

K Yamamoto1, Y Fukui, Y Esaki, T Inamitsu, T Sudo, K Yamane, N Kamikawaji, A Kimura, T Sasazuki.   

Abstract

Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4+ T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 307-319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4+ T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006580      PMCID: PMC2191563          DOI: 10.1084/jem.180.1.165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

Authors:  G Cammarota; A Scheirle; B Takacs; D M Doran; R Knorr; W Bannwarth; J Guardiola; F Sinigaglia
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

Review 2.  The major histocompatibility complex and the quest for origins.

Authors:  J Klein; N Takahata
Journal:  Immunol Rev       Date:  1990-02       Impact factor: 12.988

3.  Characterization of the specificity of peptide binding to four DR haplotypes.

Authors:  D O'Sullivan; J Sidney; E Appella; L Walker; L Phillips; S M Colón; C Miles; R W Chesnut; A Sette
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

Review 4.  The role of CD4 in T-cell activation: accessory molecule or co-receptor?

Authors:  C A Janeway
Journal:  Immunol Today       Date:  1989-07

Review 5.  Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice.

Authors:  H Lemke; G J Hämmerling; U Hämmerling
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  The MHC-binding and gp120-binding functions of CD4 are separable.

Authors:  D Lamarre; A Ashkenazi; S Fleury; D H Smith; R P Sekaly; D J Capon
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

8.  Expression of the human MHC, HLA-DQW6 genes alters the immune response in C57BL/6 mice.

Authors:  Y Nishimura; T Iwanaga; T Inamitsu; Y Yanagawa; M Yasunami; A Kimura; K Hirokawa; T Sasazuki
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

9.  Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice.

Authors:  S K Lawrance; L Karlsson; J Price; V Quaranta; Y Ron; J Sprent; P A Peterson
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

10.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

View more
  9 in total

1.  Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.

Authors:  Florian C Kurschus; Thilo Oelert; Birgit Liliensiek; Pascale Buchmann; David C Wraith; Günter J Hämmerling; Bernd Arnold
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

Review 2.  Transgenic models of autoimmune disease.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 3.  HLA transgenic mice as humanized mouse models of disease and immunity.

Authors:  V Taneja; C S David
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 4.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

5.  Development of T cell lines sensitive to antigen stimulation.

Authors:  Theodore Williams; Harsha S Krovi; Laurie G Landry; Frances Crawford; Niyun Jin; Anita Hohenstein; Megan E DeNicola; Aaron W Michels; Howard W Davidson; Sally C Kent; Laurent Gapin; John W Kappler; Maki Nakayama
Journal:  J Immunol Methods       Date:  2018-08-28       Impact factor: 2.303

6.  HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease.

Authors:  B D Schwartz
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

7.  HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.

Authors:  Hanna Lundgren; Klara Martinsson; Karin Cederbrant; Johan Jirholt; Daniel Mucs; Katja Madeyski-Bengtson; Said Havarinasab; Per Hultman
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis.

Authors:  G H Nabozny; J M Baisch; S Cheng; D Cosgrove; M M Griffiths; H S Luthra; C S David
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.

Authors:  D M Altmann; D C Douek; A J Frater; C M Hetherington; H Inoko; J I Elliott
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.